Quantitative myocardial infarction on delayed enhancement MRI. Part II: Clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 3, 2006, Pages 309-314

  Hsu, Li Yueh ^a   Ingkanisorn, W Patricia ^a   Kellman, Peter ^a   Aletras, Anthony H ^a   Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Computer aided diagnosis; Contrast agent; Gadolinium; Magnetic resonance imaging; Myocardial infarction; Myocardial viability

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ADULT; AGED; ALGORITHM; ANALYTIC METHOD; ARTICLE; AUTOMATION; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DATA ANALYSIS; HEART INFARCTION SIZE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; VALIDATION PROCESS;

ADULT; AGED; ALGORITHMS; CONTRAST MEDIA; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBSERVER VARIATION;

EID: 33644847587     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20495     Document Type: Article

References (15)

1. Kim RJ, Fieno DS, Parrish RB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999:100:1992-2002.
2. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000:36:1985-1991.
3. Wellnhofer E, Olartu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 2004:109:2172-2174.
4. Kim RJ, Manning WJ. Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? Circulation 2004:109:2476-2479.
5. Gonzalez RC, Woods RE. Digital image processing. Reading, MA: Addison Wesley; 1992.
6. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase sensitive inversion recovery for detecting myocardial infarction using Gadolinium delayed hyperenhancement. Magn Reson Med 2002:47:362-383.
7. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979:86:420-428.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986:1:307-310.
9. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000:343:1145-1453.
10. Petersen SE, Mohrs OK, Horstick G, et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 2004:6:541-548.
11. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement with MR imaging compared with 201ST1 SPECT imaging. Radiology 2004:232:49-57.
12. Setser RM, Bexell DG, O'Donnell TP, et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2003:18:434-441.
13. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002:106:2322-2327.
14. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004:43:2253-2259.
15. LC Amado, BL Gerber, SN Gupta, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004:44:2383-2389.